Since plenty of studies have shown that EGCG may have the potential to improve the glycemic profiles in patients with diabetes, we selected DPP4 protein as a receptor for molecular docking to study whether EGCG can imitate the action of DPP4 inhibitors with few side effects. This evidence concerns the gene DPP4 and diabetes mellitus.